David is head of our latent disease and legacy solutions group. Described by The Legal 500 as "brilliant", David's primary practice is the effective resolution of asbestos related and carcinogenic claims for composite insurers and multinational companies.
David is head of our latent disease and legacy solutions group. Described by The Legal 500 as "brilliant", David's primary practice is the effective resolution of asbestos related and carcinogenic claims for composite insurers and multinational companies.
David is an award winning defendant PI lawyer for his pioneering work on a conciliatory approach to the early resolution of mesothelioma claims. His collaborative approach seeks to achieve resolution of this type of claim in the shortest possible time, preferably within the claimant's lifetime. This ensures reduced indemnity spend and effective management of insurers' IBNR.
He has a particular interest in chemical poisoning, pollution and contamination claims resulting in losses for insurer clients. David specialises in legacy issues in the emerging markets and advises on historical claims legacies globally.
Experience
Provides strategic advice to, and is retained by, the ABI and its members following the MoJ consultation into mesothelioma claims. David engages in a collaborative approach to mesothelioma cases for his clients ensuring best practice and lowest indemnity spend.